Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for risk- benefit
Most Correlated Studies
- Neuroblastoma IMR-32 and BE(2)-C cell lines with siRNA knockdown of histone deacetylase HDAC11
- Neuroblastoma NB-1 cells treated with only HDAC inhibitor SAHA, PI3K/mTOR inhibitor BEZ-235, or both
- ER+ and ER- breast cancer in patients treated preventatively with tamoxifen
- HER2+ breast cancer brain metastases and HER2+ nonmetastatic primary breast cancers
- Prognostic and Predictive Gene Signature for Adjuvant Chemotherapy in Resected Non-Small Cell Lu
Most Relevant Literature
- Patient-based benefit-risk assessment of medicines: development, refinement, and validation of a con…
- A comprehensive approach to benefit-risk assessment in drug development.
- Net clinical benefit of antiplatelet therapy was affected by patient preferences: A personalized ben…
- Multimethod quantitative benefit-risk assessment of treatments for moderate-to-severe osteoarthritis…
- Benefit-Risk Analysis of Buprenorphine for Pain Management.
Most Relevant Clinical Trials
- Risk and Benefit Informed MTM Pharmacist Intervention in Heart Failure
- Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Lung Cancer…
- Risks and Benefits of Naloxone Prescribing
- Risks and Benefits of Urinary Catheter in Elective Cesarean Section
- Risk and Benefit Assessment of Hypnotic Agents for Sleep Disorders Among Elderly
